Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B John

Showing results (451-460 of 612) with videos related to

Pageof 62
Sort By:
The American Journal of Cardiology|October 18, 2022
Comparison of Outcomes of Invasive or Conservative Management of Chronic Coronary Disease in Four Randomized Controlled TrialsKreton Mavromatis, William E Boden, David J Maron, et al.
Journal of Cardiovascular Computed Tomography|September 21, 2011
Rationale and design of the DeFACTO (Determination of Fractional Flow Reserve by Anatomic Computed Tomographic AngiOgraphy) studyJames K Min, Daniel S Berman, Matthew J Budoff, et al.
The Canadian Journal of Cardiology|June 26, 2016
Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)G B John Mancini, Steven Baker, Jean Bergeron, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|May 2, 2009
International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programmeFrederick D Richard Hobbs, Gianfranco Gensini, Giovanni B John Mancini, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 2011
Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in miceSally M Amos, Hollie J Pegram, Jennifer A Westwood, et al.
Plos One|September 30, 2014
Foxp3 expression in macrophages associated with RENCA tumors in miceChristel Devaud, Carmen S M Yong, Liza B John, et al.
The American Journal of Cardiology|January 28, 2010
Impact of left ventricular ejection fraction on clinical outcomes over five years after infarct-related coronary artery recanalization (from the Occluded Artery Trial [OAT])Mariusz Kruk, Christopher E Buller, James Enlou Tcheng, et al.
The Journal of Biological Chemistry|January 7, 2011
Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in miceShigehiro Doi, Yonglong Zou, Osamu Togao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2013
Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cellsLiza B John, Christel Devaud, Connie P M Duong, et al.
Circulation. Cardiovascular Quality and Outcomes|May 13, 2018
Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)Zugui Zhang, Philip Jones, William S Weintraub, et al.
Pageof 62

Showing results (451-460 of 612) with videos related to

Sort By:
Pageof 62
The American Journal of Cardiology|October 18, 2022
Comparison of Outcomes of Invasive or Conservative Management of Chronic Coronary Disease in Four Randomized Controlled TrialsKreton Mavromatis, William E Boden, David J Maron, et al.
Journal of Cardiovascular Computed Tomography|September 21, 2011
Rationale and design of the DeFACTO (Determination of Fractional Flow Reserve by Anatomic Computed Tomographic AngiOgraphy) studyJames K Min, Daniel S Berman, Matthew J Budoff, et al.
The Canadian Journal of Cardiology|June 26, 2016
Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)G B John Mancini, Steven Baker, Jean Bergeron, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|May 2, 2009
International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programmeFrederick D Richard Hobbs, Gianfranco Gensini, Giovanni B John Mancini, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 2011
Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in miceSally M Amos, Hollie J Pegram, Jennifer A Westwood, et al.
Plos One|September 30, 2014
Foxp3 expression in macrophages associated with RENCA tumors in miceChristel Devaud, Carmen S M Yong, Liza B John, et al.
The American Journal of Cardiology|January 28, 2010
Impact of left ventricular ejection fraction on clinical outcomes over five years after infarct-related coronary artery recanalization (from the Occluded Artery Trial [OAT])Mariusz Kruk, Christopher E Buller, James Enlou Tcheng, et al.
The Journal of Biological Chemistry|January 7, 2011
Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in miceShigehiro Doi, Yonglong Zou, Osamu Togao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2013
Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cellsLiza B John, Christel Devaud, Connie P M Duong, et al.
Circulation. Cardiovascular Quality and Outcomes|May 13, 2018
Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)Zugui Zhang, Philip Jones, William S Weintraub, et al.
Pageof 62